Diabetes Technology and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.4 | Q1 | 90.0% | 2.663 | Q1 | 97.1% |
| 2024 | 6.3 | Q1 | 88.1% | 3.609 | Q1 | 98.3% |
| 2023 | 5.7 | Q1 | 84.6% | 2.957 | Q1 | 97.8% |
| 2022 | 5.4 | Q1 | 78.6% | 2.374 | Q1 | 96.8% |
| 2021 | 7.3 | Q1 | 84.4% | 2.660 | Q1 | 97.6% |
| 2020 | — | — | 2.142 | Q1 | 96.1% | |
| 2019 | — | — | 1.819 | Q1 | 94.8% | |
| 2018 | — | — | 1.800 | Q1 | 94.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF